In our manuscript, we demonstrate significant up-regulation of the key immunosuppressive checkpoint molecule, PDL1, in glioma cells after treatment with MLN4924, and thus, PDL1-dependent T-cell energy after an encounter with glioma cells. The gene discussed is CD274; the disease is glioma.